Invitation: From July 27 to July 29, 20≈α23, Haibu invites you to S♥ ¶henzhen Ping Shan for the Shen♣€ ↕zhen International Biomedical ≈↕Industry Innovation Development Con&★ference.
Classification:
Recent Events
Release time:
2023-09-18
Guided by the Shenzhen Munici₽♠γpal People's Government and hosted≠"✔ by the Shenzhen Pingshan Distri₩ct People's Government and other instit→'✔utions, the '2023 Shenzhen Internationa≤✔γ•l Biomedical Industry Innovation Develλ→₹opment Conference' will be held from•β July 27 to 29, 2023, at the Grand Sky<←≈light International Ho÷↑tel in Pingshan, Shen≈φ←♠zhen.
The conference is themed 'Cross-Border "Integration, Deep into the Future∞ ' and will feature a closed-doo'α±≠r meeting for pharmaceutical leaders®≥, a keynote forum, and nine s≈<∑pecialized thematic forums. It wil$✘σσl conduct in-depth discussions on✘Ω topics such as the latest nδλ™ational pharmaceuticσπ>↕al health industry po>§licies, cutting-edge tec₩$§hnologies and investments,♣≤≥® integration of IT and BT, γ₹achievement transformation and indust Ω&'ry-university-researc♥≠↑h cooperation, going global and int♥✘↕→ernationalization, etc., ∏ εpromoting cross-border integrationβ× with the pioneering spiα↑rit of Shenzhen to dr•♠✔ive breakthroughs in industri'•al development.
- Haibu Booth:A01, you are welcome to visit our bo∑♦♥oth for discussions.
- Conference Time:July 28-29, 2023
Beijing Haibu Pharmac§¶←eutical Technology Co., Ltd. (referred ¥→to as 'Haibu Pharmaceutical') was es♥λtablished in 2005 anπ♠πd is a high-tech enter↔₩prise with 'chemical dr♣ ♠γug research and development' ₹≥↑as its core capability.∑♥₽ It has a research and×¥γ× development center ✔β•in Beijing, an active pharmaceuti€πcal ingredient (API) and formulatio♣δ& n pilot verification center§ ☆, and a GMP industrial produφδction base. The comp♥₩any mainly engages i "×n CRO services for APIs andβ"& formulations, MAH joint licensing, AP σ₹I-related declarations,σ♣ as well as commercial s•®σupply of pharmaceuti↔™α♠cal intermediates.
It has rich experience in R&D∞ transfer production, registratio£©≈n declaration of various dφ∑osage forms including ch×∞αemical APIs, oral solids, li quid formulations, sterile♠→₹' injections, external£ ↕ preparations etc. The R&D producφ≤πts cover multiple therapeuticα₩↑÷ areas such as anti-tumor, anti-deprε≤ession, anti-epilepsy, a&≤αnti-anxiety, cardiovascular d♠↑iseases, digestive system diseases♥&×₹, respiratory system dis©✔₹eases etc.
Haibu Pharmaceutical has been aw★♣arded the title of 'To✔β÷p 20 Chinese Pharmaceu←∑σtical R&D Companies' foφ≈r several consecutive ye← ε★ars and recognized as a 'Spec&₹♥ialized & Innovative Enterpris₹α→e' in Beijing; a 'National Hig∑∑h-tech Enterprise'; a 'Beijing Science •& Technology Research Devel₹×→opment Institution';↑←↓∑ and a 'Beijing Yizhuang♦÷ Enterprise Innovation Ce✔€nter', among others.
Beijing Hope Pharmaceutical Co., Ltd.♦π
